Cystic fibrosis carrier population screening: A review

Genetic Testing

Volumn 1, Issue 1, 1997, Pages 53-59

  Rowley, Peter T ^a   Loader, Starlene ^a   Levenkron, Jeffrey C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CLINICAL TRIAL; CYSTIC FIBROSIS; FEMALE; GENETIC SCREENING; GENETICS; GENETICS AND REPRODUCTION; HETEROZYGOTE DETECTION; HUMAN; MALE; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; SCHOOL;

GENETICS AND REPRODUCTION;

ADOLESCENT; ADULT; CLINICAL TRIALS; CYSTIC FIBROSIS; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MALE; PREGNANCY; PRENATAL DIAGNOSIS; SCHOOLS;

EID: 0031292156     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1997.1.53     Document Type: Review

References (48)

1. AXWORTHY, D., BROCK, D.J.H., BOBROW, M., and MARTEAU, T.M., for the UK Cystic Fibrosis Follow-up Study Group. (1996). Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. Lancet 347, 1443-1446.
2. BALFOUR-LYNN, I., MADGE, S., and DINWIDDIE, R. (1995). Testing carrier status in siblings of patients with cystic fibrosis. Arch. Dis. Childhood 72, 167-168.
3. BEAUDET, A.L. (1990). Carrier screening for cystic fibrosis. Am. J. Hum. Genet. 47, 603-605.
4. BEKKER, H., MODELL, M., DENNISS, G., SILVER, A., MATHEW, C., BOBROW, M., and MARTEAU, T. (1993). Uptake of cystic fibrosis testing in primary care: Supply push or demand pull? B.M.J. 306, 1584-1586.
5. BEKKER, H., DENNISS, G., MODELL, M., BOBROW, M., and MARTEAU, T. (1994). The impact of population based screening for carriers of cystic fibrosis. J. Med. Genet. 31, 364-368.
6. BIESECKER, L., BOWLES-BIESECKER, B., COLLINS, F., KABACK, M., and WILFOND, B.A. (1992). General population screening for cystic fibrosis is premature. Am. J. Hum. Genet. 50, 438-439.
7. BOTKIN, J.R., and ALEMAGNO, S. (1992). Carrier screening for cystic fibrosis: A pilot study of the attitudes of pregnant women. Am. J. Pub. Health 82, 723-725.
8. BROCK, D.J.H. (1995). Heterozygote screening for cystic fibrosis. Eur. J. Hum. Genet. 3, 2-13.
9. BROCK, D.J.H. (1996). Prenatal screening for cystic fibrosis: 5 years' experience reviewed. Lancet 347, 148-150.
10. CLAUSEN, H., BRANDT, N.J., SCHWARTZ, M., and SKOVBY, F. (1996). Psychological impact of carrier screening for cystic fibrosis among pregnant women. Eur. J. Hum. Genet. 4, 120-123.
11. CLAYTON, E.W., HANNIG, V.L., PFOTENHAUER, J.P., PARKER, R.A., CAMPBELL, P.W., III, and PHILLIPS, J.A., III. (1996). Lack of interest by nonpregnant couples found in population-based cystic fibrosis carrier screening. Am. J. Hum. Genet. 58, 617-627.
12. DECRUYENAERE, M., EVERS-KIEBOOMS, G., DENAYER, L., and VAN DEN BERGHE, H. (1992). Cystic fibrosis: Community knowledge and attitudes towards carrier screening and prenatal diagnosis. Clin. Genet. 41, 189-196.
13. DOHERTY, R.A., PALOMAKI, G.E., KLOZA, E.M., ERICKSON, J.L., DOSTAL, D.A., and HADDOW, J.E. (1994). Prenatal screening for cystic fibrosis. Lancet 343, 172-173.
14. DONALDSON, C., SHACKLEY, P., ABDALLA, M., and MIEDZY-BRODZKA, Z. (1995). Willingness to pay for antenatal carrier screening for cystic fibrosis. Health Economics 4, 439-452.
15. FANOS, J.H., and JOHNSON, J.P. (1995). Perception of carrier status by cystic fibrosis siblings. Am. J. Hum. Genet. 57, 431-438.
16. FITZSIMMONS, S.C. (1997). Cystic Fibrosis Foundation.
17. GILBERT, F. (1990). Is population screening for cystic fibrosis appropriate now? Am. J. Hum. Genet. 46, 394-395.
18. GREEN, J.M. (1992). Principles and practicalities of carrier screening: Attitudes of recent parents. J. Med. Genet. 29, 313-319.
19. HARRIS, H., SCOTCHER, D., HARTLEY, N., WALLACE, A., CRAUFURD, D., and HARRIS, R. (1993). Cystic fibrosis carrier testing in early pregnancy by general practitioners. B.M.J. 306, 1580-1583.
20. HARRIS, H., SCOTCHER, D., HARTLEY, N., WALLACE, A., CRAUFURD, D., and HARRIS, R. (1996). Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. Brit. J. Gen. Pract. 46, 225-227.
21. JUNG, U., URNER, U., GRADE, K., and COUTELLE, C. (1994). Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population. Hum. Genet. 94, 19-24.
22. KAPLAN, F., CLOW, C., and SCRIVER, C.R. (1991). Cystic fibrosis carrier screening by DNA analysis: A pilot study of attitudes among participants. Am. J. Hum. Genet. 49, 240-242.
23. KEREM, E., and LYNCH, A. (1991). Screening for cystic fibrosis: Ethical and social issues. Am. Rev. Resp. Dis. 143, 457-460.
24. LOADER, S., CALDWELL, P., KOZYRA, A., LEVENKRON, J.C., BOEHM, C.D., KAZAZIAN, H.H., JR., and ROWLEY, P.T. (1996). Cystic fibrosis carrier population screening in the primary care setting. Am. J. Hum. Genet. 59, 234-247.
25. MARTEAU, T.M., DUNDAS, R., and AXWORTHY, D. (1997). Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: The effects of test result and gender. Health Psychol. 16, 51-62.
26. MENNIE, M.E., GILFILLAN, A., COMPTON, M., CURTIS, L., LISTON, W.A., PULLEN, I., WHYTE, D.A., and BROCK, D.J.H. (1992). Prenatal screening for cystic fibrosis. Lancet 340, 214-216.
27. MENNIE, M.E., COMPTON, M.E., GILFILLAN, A., LISTON, W.A., PULLEN, I., WHYTE, D.A., and BROCK, D.J.H. (1993). Prenatal screening for cystic fibrosis: Psychological effects on carriers and their partners. J. Med. Genet. 30, 543-548.
28. MIEDZYBRODZKA, Z., HALL, M.H., MOLLISON, J., TEMPLETON, A., RUSSELL, I.T., DEAN, J.C.S., KELLY, K.F., MARTEAU, T.M., and HAITES, N.E. (1995a). Antenatal screening for carriers of cystic fibrosis: Randomized trial of stepwise ν couple screening. B.M.J. 310, 353-357.
29. MIEDZYBRODZKA, Z., SEMPER, J., SCHACKLEY, P., ABDALLA, M., and DONALDSON, C. (1995b). Stepwise or couple antenatal carrier screening for cystic fibrosis? Women's preferences and willingness to pay. J. Med. Genet. 32, 282-283.
30. MITCHELL, J., SCRIVER, C.R., CLOW, C.L., and KAPLAN, F. (1993). What young people think and do when the option for cystic fibrosis carrier testing is available. J. Med. Genet. 30, 538-542.
31. MODELL, M. (1993). Screening for carriers of cystic fibrosis - A general practitioner's perspective. B.M.J. 307, 849-852.
32. RIORDAN, J.R., ROMMENS, J., KEREM, B., ALON, N., ROZMAHEL, R., GRZEKZAK, Z., ZIELENSKI, J., LOK, S., PLAVSIC, N., CHOU, J.L., DRUMM, M.L., IANNUZZI, M.C., COLLINS, F.S., and TSUI, L.C. (1989). Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1065-1073.
33. ROMMENS, J.M., IANNUZZI, M.C., KEREM, B., DRUMM, M.L., MELMER, G., DEAN, M., ROZMAHEL, R., COLE, J.L., KENNEDY, D., HIDAKA, N., ZSIGA, M., BUCHWALD, M., RIORDAN, J.R., TSUI, L.C., and COLLINS, F.S. (1989). Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245, 1059-1065.
34. ROWLEY, P.T., LOADER, S., and KAPLAN, R.M. Cystic fibrosis carrier population screening: An economic evaluation (Submitted).
35. ROWLEY, P.T., LOADER, S., LEVENKRON, J.C., and PHELPS, C.E. (1993). Cystic fibrosis carrier screening: Knowledge and attitudes of prenatal care providers. Am. J. Prev. Med. 9, 261-266.
36. SCHWARTZ, M., JOHANSEN, H.K., KOCH, C., and BRANDT, N.J. (1990). Frequency of the ΔF508 mutation on cystic fibrosis chromosomes in Denmark. Hum. Genet. 85, 427-428.
37. SCHWARTZ, M., BRANDT, N.J., and SKOVBY, F. (1993). Screening for carriers of cystic fibrosis among pregnant women: A pilot study. Eur. J. Hum. Genet. 1, 239-244.
38. SCRIVER, C.R., and FUJIWARA, T.M. (1992). Cystic fibrosis genotypes and views on screening are both heterogeneous and population related. Am. J. Hum. Genet. 51, 943-950.
39. SORENSON, J.R., DEVELLIS, B.M., CHEUVRONT, J.B., CALLANAN, N.P., and TALTON, S.L. (1994). Carrier testing among CF patients' first and second degree relatives. Am. J. Hum. Genet. 55, A22.
40. SURH, L.C., CAPPELLI, M., MACDONALD, N.E., METTLER, G., and DALES, R.E. (1994). Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process. Arch. Ped. Adolesc. Med. 148, 632-637.
41. TAMBOR, E.S., BERNHARDT, B.A., CHASE, G.A., FADEN, R.R., GELLER, G., HOFMAN, K.J., and HOLTZMAN, N.A. (1994). Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am. J. Hum. Genet. 55, 626-637.
42. WAKE, S.A., ROGERS, C.J., COLLEY, P.W., HIEATT, E.A., JENNER, C.F., and TURNER, G.M. (1996). Cystic fibrosis carrier screening in two New South Wales country towns. Med. J. Australia 164, 471-474.
43. WATSON, E.K., MAYALL, E., CHAPPLE, J., DALZIEL, M., HARRINGTON, K., WILLIAMS, C., and WILLIAMSON, R. (1991). Screening for carriers of cystic fibrosis through primary health care services. B.M.J. 303, 504-507.
44. WELKENHUYSEN, M., EVERS-KIEBOOMS, G., DECRUYENAERE, M., VAN DEN BERGHE, H., BANDE-KNOPS, J., and VAN GERVEN, V. (1996). Adolescents' attitudes towards carrier testing for cystic fibrosis and its relative stability over time. Eur. J. Hum. Genet. 4, 52-62.
45. WELSH, M.J., TSUI, L.-C., BOAT, T.F., and BEAUDET, A.L. (1995). Cystic fibrosis. In The Metabolic and Molecular Bases of Inherited Disease. Vol. III, C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds. (McGraw-Hill, Inc., New York), p. 3799.
46. WILFOND, B.S. (1995). Screening policy for cystic fibrosis. Hastings Center Report, S21-S23.
47. WILFOND, B.S., and FOST, N. (1990). The cystic fibrosis gene: Medical and social implications for heterozygote detection. JAMA 263, 2777-2783.
48. WITT, D.R., SCHAEFER, C., HALLAM, P., WI, S., BLUMBERG, B., FISHBACH, A., HOLTZMAN, J., KORNFELD, S., LEE, R., NEMZER, L., and PALMER, R. (1996). Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am. J. Hum. Genet. 58, 823-835.